मस्तिष्क संबंधी विकार

World Brain Mapping and Therapeutic Initiative: A proposed G20 priority due to Major Impact of the Cost of Neurological Disorders on the World Economy

Abstract

Kuldip S Sidhu and Babak Kateb

According to the recent World Health Organization’s large-scale studies, about a third of the adult worldwide population suوٴer from a mental disorder such as depression, anxiety and schizophrenia. If also taken together with neurological disorders, such as dementia and stroke, these “disorders of the brain” account for 13% of the global disease burden. Нis surpasses both cardiovascular diseases (5%) and cancer (10%). Countries with the highest rate of burden >650 Disability Adjusted Life Years [DALYs] per 100,000 population included the USA, UK, Russia, and Australia. Нe annual cost of taking care of patients with neurological disorders in the US alone approaches $400B of which $200B is for Alzheimer patients. We believe that this cost in 10 years could reach to $1T in the US alone. In China 975,000 people die annually from brain trauma alone and the Alzheimer population in the Australasia corridor is rapidly on the rise. Нus, European Union, China, India, Japan and Australia are not immune from such high cost of healthcare despite having 100% government insurance